Resource title

The role of HTA in coverage and pricing decisions: a cross-country comparison

Resource image

image for OpenScout resource :: The role of HTA in coverage and pricing decisions: a cross-country comparison

Resource description

Since the late 1970s, many European countries have established health technology assessment (HTA) systems to inform coverage and pricing decisions. These countries use HTA to systematically determine the relative ‘value for money’ provided by new technologies and to give providers and patients information to make treatment choices. This, in turn, serves to encourage the efficient and effective use of health technologies and to support innovation by identifying and rewarding high-value products. This overview article explores the use of HTA in coverage and pricing decisions, with a focus on pharmaceuticals, in six European countries with established HTA systems – Denmark, England, France, Germany, the Netherlands and Sweden.

Resource author

Resource publisher

Resource publish date

Resource language

en

Resource content type

Resource resource URL

http://eprints.lse.ac.uk/26129/

Resource license